Agilent Technologies Total Non-Operating Income/Expense 2010-2025 | A
Agilent Technologies annual/quarterly total non-operating income/expense history and growth rate from 2010 to 2025. Total non-operating income/expense can be defined as the sum of all non-operating expenses for the given industry.
- Agilent Technologies total non-operating income/expense for the quarter ending April 30, 2025 was $-40M, a 463.64% decline year-over-year.
- Agilent Technologies total non-operating income/expense for the twelve months ending April 30, 2025 was $-46M, a 212.2% decline year-over-year.
- Agilent Technologies annual total non-operating income/expense for 2024 was $0.033B, a 400% decline from 2023.
- Agilent Technologies annual total non-operating income/expense for 2023 was $-0.011B, a 90.35% decline from 2022.
- Agilent Technologies annual total non-operating income/expense for 2022 was $-0.114B, a 976.92% decline from 2021.
| Agilent Technologies Annual Total Non-Operating Income/Expense (Millions of US $) |
|
|---|---|
| 2024 | $33 |
| 2023 | $-11 |
| 2022 | $-114 |
| 2021 | $13 |
| 2020 | $-4 |
| 2019 | $-22 |
| 2018 | $42 |
| 2017 | $-4 |
| 2016 | $-71 |
| 2015 | $-42 |
| 2014 | $-190 |
| 2013 | $-93 |
| 2012 | $-76 |
| 2011 | $-39 |
| 2010 | $126 |
| 2009 | $-40 |
| Agilent Technologies Quarterly Total Non-Operating Income/Expense (Millions of US $) |
|
|---|---|
| 2025-04-30 | $-40 |
| 2025-01-31 | $-9 |
| 2024-10-31 | $-7 |
| 2024-07-31 | $10 |
| 2024-04-30 | $11 |
| 2024-01-31 | $19 |
| 2023-10-31 | $12 |
| 2023-07-31 | $-1 |
| 2023-04-30 | $-6 |
| 2023-01-31 | $-16 |
| 2022-10-31 | $-16 |
| 2022-07-31 | $-14 |
| 2022-04-30 | $-27 |
| 2022-01-31 | $-57 |
| 2021-10-31 | $53 |
| 2021-07-31 | $-9 |
| 2021-04-30 | $-15 |
| 2021-01-31 | $-16 |
| 2020-10-31 | $-16 |
| 2020-07-31 | $-11 |
| 2020-04-30 | $19 |
| 2020-01-31 | $4 |
| 2019-10-31 | $-19 |
| 2019-07-31 | $-3 |
| 2019-04-30 | $2 |
| 2019-01-31 | $-2 |
| 2018-10-31 | |
| 2018-07-31 | $21 |
| 2018-04-30 | $17 |
| 2018-01-31 | $4 |
| 2017-10-31 | $27 |
| 2017-07-31 | $-8 |
| 2017-04-30 | $-10 |
| 2017-01-31 | $-13 |
| 2016-10-31 | $-32 |
| 2016-07-31 | $-12 |
| 2016-04-30 | $-14 |
| 2016-01-31 | $-13 |
| 2015-10-31 | $-13 |
| 2015-07-31 | $-16 |
| 2015-04-30 | $-11 |
| 2015-01-31 | $-2 |
| 2014-10-31 | $-89 |
| 2014-07-31 | $-46 |
| 2014-04-30 | $-25 |
| 2014-01-31 | $-27 |
| 2013-10-31 | $-31 |
| 2013-07-31 | $-24 |
| 2013-04-30 | $-15 |
| 2013-01-31 | $-22 |
| 2012-10-31 | $-22 |
| 2012-07-31 | $-32 |
| 2012-04-30 | $-7 |
| 2012-01-31 | $-15 |
| 2011-10-31 | $-20 |
| 2011-07-31 | |
| 2011-04-30 | $-6 |
| 2011-01-31 | $-13 |
| 2010-10-31 | $40 |
| 2010-07-31 | $112 |
| 2010-04-30 | $-15 |
| 2010-01-31 | $-11 |
| 2009-10-31 | $8 |
| 2009-07-31 | $-40 |
| 2009-04-30 | $-11 |
| 2009-01-31 | $3 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $34.480B | $6.510B |
| Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $233.904B | 28.13 |
| Boston Scientific (BSX) | United States | $154.336B | 38.64 |
| Stryker (SYK) | United States | $150.874B | 31.55 |
| EssilorLuxottica (ESLOY) | France | $127.819B | 0.00 |
| Medtronic (MDT) | Ireland | $113.364B | 16.07 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.609B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.066B | 26.28 |
| ResMed (RMD) | United States | $37.677B | 28.30 |
| GE HealthCare Technologies (GEHC) | United States | $34.831B | 16.54 |
| Terumo (TRUMY) | Japan | $25.244B | 32.79 |
| Koninklijke Philips (PHG) | Netherlands | $23.274B | 16.33 |
| Insulet (PODD) | United States | $21.186B | 83.16 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.532B | 11.90 |
| Baxter (BAX) | United States | $15.914B | 11.88 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.262B | 0.00 |
| Demant (WILYY) | Denmark | $8.971B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.846B | 23.82 |
| Lantheus Holdings (LNTH) | United States | $5.564B | 14.03 |
| Prestige Consumer Healthcare (PBH) | United States | $3.952B | 17.66 |
| Perrigo (PRGO) | Ireland | $3.739B | 9.48 |
| Haemonetics (HAE) | United States | $3.693B | 16.82 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.456B | 28.72 |
| ICU Medical (ICUI) | United States | $3.333B | 24.58 |
| QuidelOrtho (QDEL) | United States | $2.042B | 14.04 |
| LeMaitre Vascular (LMAT) | United States | $1.907B | 42.62 |
| AtriCure (ATRC) | United States | $1.572B | 0.00 |
| Acuren (TIC) | United States | $1.378B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.258B | 12.77 |
| Green Thumb Industries (GTBIF) | United States | $1.164B | 26.19 |
| Neogen (NEOG) | United States | $1.157B | 14.81 |
| Phibro Animal Health (PAHC) | United States | $1.135B | 14.51 |
| BioLife Solutions (BLFS) | United States | $1.085B | 0.00 |
| InMode (INMD) | Israel | $0.958B | 9.66 |
| Kestra Medical Technologies (KMTS) | United States | $0.805B | 0.00 |
| Owens & Minor (OMI) | United States | $0.712B | 5.90 |
| CeriBell (CBLL) | United States | $0.684B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.680B | 0.00 |
| Evolus (EOLS) | United States | $0.598B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.555B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.542B | 0.00 |
| Valneva SE (VALN) | France | $0.494B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.468B | 0.00 |
| Surmodics (SRDX) | United States | $0.429B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.363B | 13.33 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.360B | 0.00 |
| Quanterix (QTRX) | United States | $0.349B | 0.00 |
| SNDL (SNDL) | Canada | $0.334B | 0.00 |
| Cerus (CERS) | United States | $0.294B | 0.00 |
| ZimVie (ZIMV) | United States | $0.285B | 12.98 |
| Viemed Healthcare (VMD) | United States | $0.283B | 23.83 |
| Sanuwave Health (SNWV) | United States | $0.271B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.264B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.255B | 75.67 |
| Brainsway (BWAY) | Israel | $0.250B | 66.20 |
| Cresco Labs (CRLBF) | United States | $0.246B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.235B | 0.00 |
| Biote (BTMD) | United States | $0.231B | 6.49 |
| OraSure Technologies (OSUR) | United States | $0.230B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.192B | 0.00 |
| Organigram Global (OGI) | Canada | $0.192B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.190B | 15.46 |
| High Tide (HITI) | Canada | $0.188B | 0.00 |
| Omeros (OMER) | United States | $0.188B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.177B | 0.00 |
| Exagen (XGN) | United States | $0.150B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.144B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.133B | 16.35 |
| Jin Medical (ZJYL) | China | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.097B | 12.48 |
| MacroGenics (MGNX) | United States | $0.092B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
| Veru (VERU) | United States | $0.089B | 0.00 |
| Apyx Medical (APYX) | United States | $0.087B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.084B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.077B | 0.00 |
| Zynex (ZYXI) | United States | $0.073B | 0.00 |
| InterCure (INCR) | Israel | $0.071B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.068B | 0.00 |
| Agape ATP (ATPC) | $0.068B | 0.00 | |
| Jushi Holdings (JUSHF) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.058B | 0.00 |
| Nephros (NEPH) | United States | $0.043B | 57.57 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.86 |
| Safety Shot (SHOT) | United States | $0.030B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.028B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.012B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |